Arm Holdings (NASDAQ:ARM) has more than tripled in valued since its Sept. 14 initial public offering. It started trading at a market capitalization of $54 billion and today is worth over $182 billion. Shares that originally went for $51 a stub now trade at $181 each. ARM stock is up 141% in 2024 alone.The tremendous drive higher in ARM stock is because of the demand frenzy for artificial intelligence, even though the CPU architecture developer only indirectly benefits from the technology. While it is the pr ...

Mindful Media/E+ via Getty Images In the past few months, I've written several Seeking Alpha articles centered on Artificial Intelligence. Last month I wrote about Broadcom Inc. (AVGO) in a June 11 article entitled "Broadcom: Eyes On AI But 5G Outperforms On Revenue," and NVIDIA Corporation (NVDA) in a June 17 article entitled "Nvidia: Why The Company And Its GPUs Will Dominate AI Processors." In a February 27, 2024 article entitled "Qualcomm: Squeezing Competitors Out Of GenAI Smartphones At The Edge." In ...

A couple of years ago, many American investors probably had never heard of British chip designer Arm (NASDAQ:ARM), which has become a Wall Street darling on the artificial intelligence hardware trend. Ignore the temptation to jump in now; it’s too late as ARM stock is grossly overvalued. Don’t get the wrong message. Arm’s a bad company, by any means. Indeed, an array of technology companies use Arm’s chip designs. But then, the market already knows this and has already baked a lot of hope and hype into the ...

BlackJack3D Arm Holdings (NASDAQ:ARM) is reaching a major paradigm shift in their target market as the firm further develops their CSS architecture. ARM has recently made a few major announcements involving the adoption of their ARM Neoverse across the hyperscalers, including Microsoft (MSFT), Oracle (ORCL), and Amazon (AMZN). As each of these firms further develop their high-performance processors to bolster the speed, reliability, and power reduction, I believe ARM will realize a significant growth opport ...

文章核心观点 - Nvidia和Arm Holdings是2024年上半年纳斯达克100指数中表现最佳的两只股票 [1][2][3] - 华尔街预期Arm股价在未来几个月将大幅下跌 [3][4] Nvidia - Nvidia是数据中心GPU和AI处理器的市场领导者 [5] - Nvidia通过硬件、软件和云服务等方式,在AI计算领域建立了难以逾越的护城河 [5][6] - 分析师预计Nvidia未来5年每股收益将以33%的年复合增长率增长 [7] Arm Holdings - Arm是智能手机和移动设备处理器的市场领导者 [9][10][11][12] - Arm的处理器架构在功耗效率方面占优势,但在计算性能方面落后于英特尔和AMD [11][12] - Arm最近在计算性能方面有所提升,并在消费电子和云计算领域获得更多市场份额 [13] - Arm 2024财年第四季度业绩超预期,但管理层预计未来增长将放缓 [14] - 分析师预计Arm未来5年每股收益将以23%的年复合增长率增长,但目前估值过高 [15][16]

The Buffett Indicator signals a significantly overvalued U.S. Stock Market and has drawn much attention to overvalued stocks to watch. With market cap over GDP at 192.6%, analysts expect returns to be only 0.6% a year including dividends from this level of overvaluation. Below, you’ll learn about three particular stocks that are overvalued but should be watched. Explore the possibility of these stocks being overpriced by looking at their P/E Ratios and PEG ratios. Then, examine their intrinsic values using ...

The semiconductor industry is the bedrock of the digital age. Semiconductors have provided the essential building blocks for computers, smartphones, and countless other electronic devices that power our modern world. As technology advances at an unprecedented pace, the demand for increasingly powerful and efficient semiconductors continues to surge. At the front of this technological revolution is artificial intelligence (AI), a transformative tech reshaping industries that is driving an insatiable need for ...

There’s more to the current rally in technology stocks than Nvidia (NASDAQ:NVDA). Nvidia stock continues to get the lion’s share of attention from the financial press. However, there are a number of other tech stocks to buy that are posting impressive gains and have exciting things happening at their underlying companies. Equally important, there are a number of tech stocks to buy now to play the booming artificial intelligence (AI) trade. Despite how it might appear reading the news these days, Nvidia is n ...

Defence's ARM-X Anti-Cancer Vaccine Inhibits Growth of Pre-Established Ovarian Cancer Resulting in Complete Responses in Treated Animals June 25, 2024 3:15 AM EDT | Source: Defence Therapeutics Inc. Vancouver, British Columbia--(Newsfile Corp. - June 25, 2024) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce that its second- gener ...

As ARM Holdings NASDAQ: ARM continues its impressive climb, market participants, be they investors, traders, or speculators, increasingly wonder if the stock's rapid rise is sustainable or has surged too quickly. Since its successful NASDAQ debut in September last year, the stock has shown remarkable performance, recently breaking above its all-time high (ATH) with solid momentum. So, let's take a closer look at the company's recent performance, fundamentals, and technical indicators to evaluate whether it' ...